Drug Profile
Research programme: survivin modulators - Avalon
Alternative Names: Survivin pathway modulators - AvalonLatest Information Update: 19 Aug 2008
Price :
$50
*
At a glance
- Originator Avalon Pharmaceuticals
- Class
- Mechanism of Action BIRC5 protein inhibitors; Protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 Aug 2008 Discontinued for Cancer in USA (unspecified route)
- 07 Nov 2006 Early research in Cancer in USA (unspecified route)